AT & S Austria Technologie & Systemtechnik (ATS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Q1 2024/25 revenue was €349.4 million, down 3.4% year-over-year due to price pressure, with both Electronics Solutions and Microelectronics impacted, but up 1.4% sequentially.
Adjusted EBITDA rose 4.4% year-over-year to €96.5 million, with an adjusted margin of 27.6%; reported EBITDA was €65 million, down 13.8%.
Net loss for the period was €-34 million, mainly due to start-up, restructuring, and higher finance costs.
Efficiency and cost optimization programs are progressing, with workforce reduction and OPEX/CAPEX savings.
Market environment remains challenging with high price pressure, but improvement is expected in H2 2024/25.
Financial highlights
EBITDA was €64.6–65 million, heavily impacted by €32 million in one-time start-up and restructuring costs.
Adjusted EBITDA margin reached 27.6% (up from 25.5% year-over-year); reported EBITDA margin was 18.5%.
Operating cash flow dropped to €14 million from €229 million year-over-year, mainly due to inventory build-up.
Net CAPEX was €92.7–93 million, down 66% year-over-year.
Net working capital ratio to revenue remains in single digits (9.3%).
Outlook and guidance
FY 2024/25 revenue guidance: €1.7–1.8 billion; adjusted EBITDA margin: 25–27%, excluding up to €88 million in one-off costs.
Midterm (2026/27) revenue guidance: €3.1 billion, EBITDA margin: 27–32%.
ROCE expected above 12% and leverage below 3x post-ramp.
CapEx for FY 2024/25 guided at €500 million, with lower levels expected in subsequent years.
Demand recovery anticipated in H2 2024/25, but price pressure to persist; efficiency programs and workforce reduction of up to 1,000 employees underway.
Latest events from AT & S Austria Technologie & Systemtechnik
- Revenue up 10% to €1.314B, EBITDA margin 23%, strong outlook despite FX and supply risks.ATS
Q3 20263 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue, EBITDA, and cash flow improved, but FX and supply chain risks persist.ATS
Q2 202616 Dec 2025 - Revenue up 3%, EBITDA margin at 26%, with major investments and cost savings; outlook cautious.ATS
Q4 202521 Nov 2025 - Revenue up 14.2% year-over-year, but net loss widened on FX and ramp-up costs.ATS
Q1 202616 Nov 2025 - Revenue and earnings fell amid price pressure, but mid-term growth targets are reaffirmed.ATS
Q2 202513 Jun 2025